{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:40:45Z","timestamp":1792456845425,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10072-026-09002-7","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T02:35:27Z","timestamp":1774838127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Peripheral inflammation predicts motor, cognitive, and disease progression in Parkinson\u2019s disease: A 4-year longitudinal study from the PPMI cohorts"],"prefix":"10.1007","volume":"47","author":[{"given":"Zonghui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8337-7732","authenticated-orcid":false,"given":"Mingchao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"1","key":"9002_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(25)00382-5","volume":"25","author":"M de Castro Fonseca","year":"2026","unstructured":"de Castro Fonseca M, Zanetti L, Fanourakis S, Sulzer DL, Mazmanian SK (2026) The gut microbiome, systemic inflammation, and autoimmunity in Parkinson\u2019s disease. Lancet Neurol 25(1):103\u2013114. https:\/\/doi.org\/10.1016\/S1474-4422(25)00382-5","journal-title":"Lancet Neurol"},{"issue":"s1","key":"9002_CR2","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.3233\/JPD-223241","volume":"12","author":"GP Williams","year":"2022","unstructured":"Williams GP, Schonhoff AM, Sette A, Lindestam Arlehamn CS (2022) Central and peripheral inflammation: connecting the immune responses of Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S129\u2013S136. https:\/\/doi.org\/10.3233\/JPD-223241","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"9002_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"9002_CR4","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2022","unstructured":"Pajares M, Rojo IA, Manda G, Bosc\u00e1 L, Cuadrado A (2022) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9(7):1687. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"key":"9002_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"issue":"1","key":"9002_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41531-025-01019-7","volume":"11","author":"P He","year":"2025","unstructured":"He P, Li Y, Huang Z, Gao Y, Duan Q, Qiu Y, Feng S, Huang R, Gong L, Ma G, Zhang Y, Shi L, Wang L, Nie K (2025) Peripheral inflammation\u2019s variable impact on cognitive and symptomatic outcomes in Parkinson\u2019s disease: a longitudinal and cross-sectional analysis. NPJ Parkinsons Dis 11(1):155. https:\/\/doi.org\/10.1038\/s41531-025-01019-7","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"9002_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41398-023-02683-0","volume":"13","author":"X Zhong","year":"2023","unstructured":"Zhong X, Qiang Y, Wang L, Zhang Y, Li J, Feng J, Cheng W, Tan L, Yu J (2023) Peripheral immunity and risk of incident brain disorders: a prospective cohort study of 161,968 participants. Transl Psychiatry 13(1):382. https:\/\/doi.org\/10.1038\/s41398-023-02683-0","journal-title":"Transl Psychiatry"},{"issue":"10","key":"9002_CR8","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/mds.28685","volume":"36","author":"L Mu\u00f1oz-Delgado","year":"2021","unstructured":"Mu\u00f1oz-Delgado L, Mac\u00edas-Garc\u00eda D, Jes\u00fas S, Mart\u00edn-Rodr\u00edguez JF, Labrador-Espinosa M\u00c1, Jim\u00e9nez-Jaraba MV, Adarmes-G\u00f3mez A, Carrillo F, Mir P (2021) Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson\u2019s Disease. Mov Disord 36(10):2426\u20132430. https:\/\/doi.org\/10.1002\/mds.28685","journal-title":"Mov Disord"},{"key":"9002_CR9","doi-asserted-by":"publisher","first-page":"125698","DOI":"10.1016\/j.jns.2025.125698","volume":"480","author":"M Shi","year":"2026","unstructured":"Shi M, Zhao H, Zhu Y, Chen M, Jiang H, Chen Z, Feng M (2026) The impact of enlarged perivascular spaces on the association among peripheral inflammation, disease progression and motor symptoms in Parkinson\u2019s disease. J Neurol Sci 480:125698. https:\/\/doi.org\/10.1016\/j.jns.2025.125698","journal-title":"J Neurol Sci"},{"issue":"19","key":"9002_CR10","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3390\/jcm11195543","volume":"11","author":"E Contaldi","year":"2022","unstructured":"Contaldi E, Magistrelli L, Cosentino M, Marino F, Comi C (2022) Lymphocyte count and neutrophil-to-lymphocyte ratio are associated with mild cognitive impairment in Parkinson\u2019s Disease: a single-center longitudinal study. J Clin Med 11(19):5543. https:\/\/doi.org\/10.3390\/jcm11195543","journal-title":"J Clin Med"},{"issue":"7","key":"9002_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140(7):1959\u20131976. https:\/\/doi.org\/10.1093\/brain\/awx118","journal-title":"Brain"},{"issue":"6","key":"9002_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/JPD-223433","volume":"13","author":"MC Brumm","year":"2023","unstructured":"Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O\u2019Grady AN, Poston KL, Tanner CM, Weintraub D, Kieburtz K, Marek K, Coffey CS, Parkinson\u2019s Progression Markers Initiative (2023) Parkinson\u2019s progression markers initiative: a milestone-based strategy to monitor Parkinson\u2019s Disease progression. J Parkinsons Dis 13(6):899\u2013916. https:\/\/doi.org\/10.3233\/JPD-223433","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"9002_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-021-01462-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Fan Q, Wu S, Wan Y, Lei Y (2021) Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson\u2019s disease. Lipids Health Dis 20(1):35. https:\/\/doi.org\/10.1186\/s12944-021-01462-4","journal-title":"Lipids Health Dis"},{"issue":"11","key":"9002_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","volume":"16","author":"JC Latourelle","year":"2017","unstructured":"Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS (2017) Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson\u2019s disease: a longitudinal cohort study and validation. Lancet Neurol 16(11):908\u2013916. https:\/\/doi.org\/10.1016\/S1474-4422(17)30328-9","journal-title":"Lancet Neurol"},{"issue":"4","key":"9002_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95(4):629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"issue":"1","key":"9002_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2014.10.026","volume":"21","author":"P Mart\u00ednez-Mart\u00edn","year":"2015","unstructured":"Mart\u00ednez-Mart\u00edn P, Rodr\u00edguez-Bl\u00e1zquez C, Alvarez M, Arakaki T, Arillo VC, Chan\u00e1 P, Fern\u00e1ndez W, Garretto N, Mart\u00ednez-Castrillo JC, Rodr\u00edguez-Violante M, Serrano-Due\u00f1as M, Ballesteros D, Rojo-Abuin JM, Chaudhuri KR, Merello M (2015) Parkinson\u2019s disease severity levels and MDS-Unified Parkinson\u2019s Disease Rating Scale. Parkinsonism Relat Disord 21(1):50\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.10.026","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"9002_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"issue":"11","key":"9002_CR18","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.3390\/ijms26115177","volume":"26","author":"J Fo\u0142ta","year":"2025","unstructured":"Fo\u0142ta J, Rzepka Z, Wrze\u015bniok D (2025) The role of inflammation in neurodegenerative diseases: Parkinson\u2019s disease, Alzheimer\u2019s disease, and multiple sclerosis. Int J Mol Sci 26(11):5177. https:\/\/doi.org\/10.3390\/ijms26115177","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9002_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41531-025-00909-0","volume":"11","author":"R Lin","year":"2025","unstructured":"Lin R, Cai G, Chen Y, Zheng J, Wang S, Xiao H, Ye Q, Xue Y, Jiang R (2025) Association of glymphatic system function with peripheral inflammation and motor symptoms in Parkinson\u2019s disease. NPJ Parkinsons Dis 11(1):62. https:\/\/doi.org\/10.1038\/s41531-025-00909-0","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"9002_CR20","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/mds.29056","volume":"37","author":"R Kim","year":"2022","unstructured":"Kim R, Kim HJ, Shin JH, Lee CY, Jeon SH, Jeon B (2022) Serum inflammatory markers and progression of nonmotor symptoms in early Parkinson\u2019s disease. Mov Disord 37(7):1535\u20131541. https:\/\/doi.org\/10.1002\/mds.29056","journal-title":"Mov Disord"},{"issue":"12","key":"9002_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/jnnp-2022-330394","volume":"94","author":"R Kim","year":"2023","unstructured":"Kim R, Kang N, Byun K, Park K, Jun JS (2023) Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson\u2019s disease: an 8-year follow-up study. J Neurol Neurosurg Psychiatry 94(12):1040\u20131046. https:\/\/doi.org\/10.1136\/jnnp-2022-330394","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9002_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41531-023-00457-5","volume":"9","author":"L Mu\u00f1oz-Delgado","year":"2023","unstructured":"Mu\u00f1oz-Delgado L, Mac\u00edas-Garc\u00eda D, Peri\u00f1\u00e1n MT, Jes\u00fas S, Adarmes-G\u00f3mez AD, Bonilla Toribio M, Buiza Rueda D, Jim\u00e9nez-Jaraba MDV, Ben\u00edtez Zamora B, D\u00edaz Belloso R, Garc\u00eda-D\u00edaz S, Mart\u00edn-B\u00f3rnez M, Pineda S\u00e1nchez R, Carrillo F, G\u00f3mez-Garre P, Mir P (2023) Peripheral inflammatory immune response differs among sporadic and familial Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):12. https:\/\/doi.org\/10.1038\/s41531-023-00457-5","journal-title":"NPJ Parkinsons Dis"},{"key":"9002_CR23","doi-asserted-by":"publisher","first-page":"1323174","DOI":"10.3389\/fimmu.2024.1323174","volume":"15","author":"R Ma","year":"2024","unstructured":"Ma R, Cui L, Cai J, Yang N, Wang Y, Chen Q, Chen W, Peng C, Qin H, Ding Y, Wang X, Yu Q, Shi Y (2024) Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES. Front Immunol 15:1323174. https:\/\/doi.org\/10.3389\/fimmu.2024.1323174","journal-title":"Front Immunol"},{"issue":"2","key":"9002_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mds.23443","volume":"26","author":"TO Dalaker","year":"2011","unstructured":"Dalaker TO, Zivadinov R, Ramasamy DP, Beyer MK, Alves G, Bronnick KS, Tysnes OB, Aarsland D, Larsen JP (2011) Ventricular enlargement and mild cognitive impairment in early Parkinson\u2019s disease. Mov Disord 26(2):297\u2013301. https:\/\/doi.org\/10.1002\/mds.23443","journal-title":"Mov Disord"},{"issue":"9","key":"9002_CR25","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/acn3.52144","volume":"11","author":"J Lucero","year":"2024","unstructured":"Lucero J, Gurnani A, Weinberg J, Shih LC (2024) Neutrophil-to-lymphocyte ratio and longitudinal cognitive performance in Parkinson\u2019s disease. Ann Clin Transl Neurol 11(9):2301\u20132313. https:\/\/doi.org\/10.1002\/acn3.52144","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"9002_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/1073858421992265","volume":"28","author":"SYH Lee","year":"2022","unstructured":"Lee SYH, Yates NJ, Tye SJ (2022) Inflammatory mechanisms in Parkinson\u2019s disease: from pathogenesis to targeted therapies. Neuroscientist 28(5):485\u2013506. https:\/\/doi.org\/10.1177\/1073858421992265","journal-title":"Neuroscientist"},{"issue":"5","key":"9002_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.29369","volume":"38","author":"L Mu\u00f1oz-Delgado","year":"2023","unstructured":"Mu\u00f1oz-Delgado L, Labrador-Espinosa M\u00c1, Mac\u00edas-Garc\u00eda D, Jes\u00fas S, Ben\u00edtez Zamora B, Fern\u00e1ndez-Rodr\u00edguez P, Adarmes-G\u00f3mez AD, Reina Castillo MI, Castro-Labrador S, Silva-Rodr\u00edguez J, Carrillo F, Garc\u00eda Sol\u00eds D, Grothe MJ, Mir P (2023) Peripheral inflammation is associated with dopaminergic degeneration in Parkinson\u2019s disease. Mov Disord 38(5):755\u2013763. https:\/\/doi.org\/10.1002\/mds.29369","journal-title":"Mov Disord"},{"key":"9002_CR28","doi-asserted-by":"publisher","first-page":"e63105","DOI":"10.2196\/63105","volume":"27","author":"JM Templeton","year":"2025","unstructured":"Templeton JM, Poellabauer C, Schneider S, Rahimi M, Braimoh T, Tadamarry F, Margolesky J, Burke S, Al Masry Z (2025) Modernizing the staging of Parkinson disease using digital health technology. J Med Internet Res 27:e63105. https:\/\/doi.org\/10.2196\/63105","journal-title":"J Med Internet Res"},{"issue":"8","key":"9002_CR29","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/brain\/awaf066","volume":"148","author":"G Moquin-Beaudry","year":"2025","unstructured":"Moquin-Beaudry G, Andriamboavonjy L, Audet S, Hamilton LK, Duquette A, Chouinard S, Panisset M, Tetreault M (2025) Mapping the peripheral immune landscape of Parkinson\u2019s disease patients with single-cell sequencing. Brain 148(8):2847\u20132860. https:\/\/doi.org\/10.1093\/brain\/awaf066","journal-title":"Brain"},{"key":"9002_CR30","doi-asserted-by":"publisher","first-page":"106794","DOI":"10.1016\/j.nbd.2025.106794","volume":"207","author":"ML Bolen","year":"2025","unstructured":"Bolen ML, Gomes BN, Gill B, Menees KB, Staley H, Jernigan J, McFarland NR, Zimmermann EM, Forsmark CE, Tansey MG (2025) Peripheral blood immune cells from individuals with Parkinson\u2019s disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs. Neurobiol Dis 207:106794. https:\/\/doi.org\/10.1016\/j.nbd.2025.106794","journal-title":"Neurobiol Dis"},{"key":"9002_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbi.2025.05.020","volume":"129","author":"KM Scott","year":"2025","unstructured":"Scott KM, Spindler LRB, Peattie ARD, Kouli A, Fryer TD, Hong YT, Camacho M, Solim I, Kahanawita L, Williams-Gray CH (2025) Multimodal markers of immune activation predict cognitive outcomes in Parkinson\u2019s disease. Brain Behav Immun 129:165\u2013178. https:\/\/doi.org\/10.1016\/j.bbi.2025.05.020","journal-title":"Brain Behav Immun"},{"issue":"10","key":"9002_CR32","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1093\/brain\/awac193","volume":"145","author":"D Bottigliengo","year":"2022","unstructured":"Bottigliengo D, Foco L, Seibler P, Klein C, K\u00f6nig IR, Del Greco MF (2022) A Mendelian randomization study investigating the causal role of inflammation on Parkinson\u2019s disease. Brain 145(10):3444\u20133453. https:\/\/doi.org\/10.1093\/brain\/awac193","journal-title":"Brain"},{"issue":"1","key":"9002_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12974-022-02481-3","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y, Yang Y, Zhao A, Luo N, Niu M, Kang W, Xie A, Lu H, Chen L, Liu J (2022) Parkinson\u2019s disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study. J Neuroinflammation 19(1):116. https:\/\/doi.org\/10.1186\/s12974-022-02481-3","journal-title":"J Neuroinflammation"},{"key":"9002_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bbi.2024.10.039","volume":"123","author":"RL McFleder","year":"2025","unstructured":"McFleder RL, Musacchio T, Keller J, Knorr S, Petschner T, Chen JZ, Muthuraman M, Badr M, Harder-Rauschenberger L, Kremer F, Asci S, Steinhauser S, Karl AK, Brotchie JM, Koprich JB, Volkmann J, Ip CW (2025) Deep brain stimulation halts Parkinson\u2019s disease-related immune dysregulation in the brain and peripheral blood. Brain Behav Immun 123:851\u2013862. https:\/\/doi.org\/10.1016\/j.bbi.2024.10.039","journal-title":"Brain Behav Immun"},{"issue":"1","key":"9002_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41531-021-00188-5","volume":"7","author":"AD Thome","year":"2021","unstructured":"Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH (2021) Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson\u2019s disease. NPJ Parkinsons Dis 7(1):41. https:\/\/doi.org\/10.1038\/s41531-021-00188-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"9002_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13073-022-01132-9","volume":"14","author":"C Sandor","year":"2022","unstructured":"Sandor C, Millin S, Dahl A, Schalkamp AK, Lawton M, Hubbard L, Rahman N, Williams N, Ben-Shlomo Y, Grosset DG, Hu MT, Marchini J, Webber C (2022) Universal clinical Parkinson\u2019s disease axes identify a major influence of neuroinflammation. Genome Med 14(1):129. https:\/\/doi.org\/10.1186\/s13073-022-01132-9","journal-title":"Genome Med"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09002-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09002-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09002-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:39:38Z","timestamp":1776242378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09002-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["9002"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09002-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study is a secondary analysis of de-identified data from the Parkinson\u2019s Progression Markers Initiative (PPMI). The PPMI study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Ethical approval was obtained from the institutional review boards or ethics committees of all participating institutions. Written informed consent was acquired from all participants prior to study enrollment. No additional ethical approval was required for the present secondary analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"388"}}